- 26 November, 2024
Is DraftKings stock a buy amid rumors of Bleacher Report acquisition?
Shares of the daily fantasy sports contest and betting operator DraftKings Inc. (NASDAQ:DKNG) on Monday gained 7.24% after news emerged that it showed interest in
Should I buy Kellogg Company shares after Argus raised its price target to $72?
Kellogg Company (NYSE: K) is a stable company with a good position in the market, but the stock price is still not able to stabilize
Media expert says Amazon has no interest in competing directly with Disney
The Wall Street Journal reported that Amazon Inc. (NASDAQ: AMZN) inched closer to acquiring MGM Studios for about $9 billion (£6.37 billion) on Tuesday. In
Amazon inches closer to finalizing MGM’s library
Amazon.com Inc. (NASDAQ: AMZN) is poised to announce a deal to acquire the famed MGM Studios Inc. for almost $9 billion, including debt, according to
Netflix stock price outlook as Amazon buys MGM
The Netflix (NASDAQ: NFLX) stock price is up by more than 0.60% in premarket trading even as competition in the streaming space increases. The stock
3 key takeaways from Nordson Corp’s Q2 earnings report
Nordson Corp. (NASDAQ: NDSN) reported its financial results for the fiscal second quarter on Monday that beat Wall Street estimates on the back of robust
Peloton will open its first-ever US manufacturing plant
Peloton Interactive Inc. (NASDAQ: PTON) plans on building a manufacturing plant in Ohio, said the home fitness equipment maker on Monday. Its first-ever U.S. factory
Apple will ‘lose the war’ against Epic
Apple Inc (NASDAQ: AAPL) has been embroiled in a legal battle with Epic Games Inc. since last August when Epic sued Apple for violating antitrust
Should you buy Nvidia stock after announcing a 4-for-1 split?
Shares of Nvidia Corp (NASDAQ:NVDA) popped more than 10% late last week following the announcement of a 4-for-1 stock split. The company said on Friday
Here’s why Scopus BioPharma gained 200% on Monday
Scopus BioPharma Inc. (NASDAQ: SCPS) said the U.S. Food and Drug Administration FDA approved its IND (investigational new drug) application on Monday for CpG-STAT3siRNA –